Monitoring response and resistance to EGFR inhibition with circulating tumor DNA in a non-small cell lung cancer patient-derived xenograft

被引：0
作者：
Do, Long H.
Pippa, Raffaella
Andrews, Warren
Chien, Yuan
Sperry, Jantzen
Nakashima, Jonathan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6690
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6690
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Circulating tumor DNA testing in advanced non-small cell lung cancer
    Moding, Everett J.
    Diehn, Maximilian
    Wakelee, Heather A.
    LUNG CANCER, 2018, 119 : 42 - 47
  • [32] Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer
    Kay T. Yeung
    Soham More
    Brian Woodward
    Victor Velculescu
    Hatim Husain
    Molecular Diagnosis & Therapy, 2017, 21 : 375 - 384
  • [33] Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA
    Yaung, Stephanie J.
    Woestmann, Corinna
    Ju, Christine
    Ma, Xiaoju Max
    Gattam, Sandeep
    Zhou, Yiyong
    Xi, Liu
    Pal, Subrata
    Balasubramanyam, Aarthi
    Tikoo, Nalin
    Heussel, Claus Peter
    Thomas, Michael
    Kriegsmann, Mark
    Meister, Michael
    Schneider, Marc A.
    Herth, Felix J.
    Wehnl, Birgit
    Diehn, Maximilian
    Alizadeh, Ash A.
    Palma, John F.
    Muley, Thomas
    CANCERS, 2022, 14 (10)
  • [34] The Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
    Grinberg, R.
    Roisman, L.
    Geva, S.
    Lefterova, M.
    Quinn, K.
    Gutman, L. Soussan
    Dvir, A.
    Yair, R.
    Twito, T.
    Lanman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S925 - S926
  • [35] EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
    Gerber, David E.
    DRUG DEVELOPMENT RESEARCH, 2008, 69 (06) : 359 - 372
  • [36] The influence of circulating tumor DNA analysis on response to immunotherapy in non-small cell lung cancer (NSCLC)
    Grinberg, R.
    Roisman, L. C.
    Geva, S.
    Soussan-Gutman, L.
    Dvir, A.
    Yair, R.
    Twito, T.
    Larman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S35 - S36
  • [37] Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA
    Goldberg, S. B.
    Narayan, A.
    Kole, A. J.
    Decker, R. H.
    Teysir, J.
    Carriero, N. J.
    Lee, A.
    Nemati, R.
    Nath, S. K.
    Mane, S. M.
    Deng, Y.
    Sukumar, N.
    Zelterman, D.
    Boffa, D. J.
    Politi, K.
    Gettinger, S. N.
    Wilson, L. D.
    Herbst, R. S.
    Patel, A. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth
    Petrek, Hannah
    Ho, Pui Yan
    Batra, Neelu
    Tu, Mei-Juan
    Zhang, Qianyu
    Qiu, Jing-Xin
    Yu, Ai-Ming
    BIOCHEMICAL PHARMACOLOGY, 2021, 189
  • [39] Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice
    Chen, Yungchang
    Zhang, Ran
    Wang, Li
    Correa, Arlene M.
    Pataer, Apar
    Xu, Yi
    Zhang, Xiaoshan
    Ren, Chenghui
    Wu, Shuhong
    Meng, Qing H.
    Fujimoto, Junya
    Jensen, Vanessa B.
    Antonoff, Mara B.
    Hofstetter, Wayne L.
    Mehran, Reza J.
    Pisimisis, George
    Rice, David C.
    Sepesi, Boris
    Vaporciyan, Ara A.
    Walsh, Garrett L.
    Swisher, Stephen G.
    Roth, Jack A.
    Heymach, John, V
    Fang, Bingliang
    CANCER, 2019, 125 (21) : 3738 - 3748
  • [40] Histological and Genetic Parental Tumor Characteristics are Conserved in Patient-derived Non-small Cell Lung Cancer Organoids
    Werner, R. S.
    Jang, J. -H.
    Kirschner, M. B.
    Opitz, I.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S614 - S614
12345